According to Rath et al (2003), the Glucantime is especially efficient in the treatment of cutaneous, mucocutnea and visceral Leishmaniose. The medicine provokes fast regression of the clinical and hematolgicas manifestations of the illness, as well as provokes the sterilization of the parasite (HEALTH DEPARTMENT, 1998). In Brazil, the medicine to the antimony base is used as first choice in the therapeutical one of leishmaniose, its formularization is constituted of antimony salt pentavalente of glucamina N-metil, is a frmaco capable to produce serious effect collateral, however is very efficient in the treatment of the cutaneous, mucocutnea Leishmaniose and visceral Leishmaniose. Its administration is endovenosa (AMATO, 2006). The medicine industry, little has contributed for the medicine development new for the treatment of the Leishmaniose, but in Brazil the used drug more in this type of treatment is the Glucantime (OAK, 2001).
The results are presented to follow in the form of folloied graphs and of the respective quarrel. Sex of the inhabitants of Oath, who had answered to the questionnaire. Source: Research of field carried through for the academics of 3 period of Pharmacy of the FIPMoc in the city of Oath 1 semester of 2010. The data of GRAF. 01 demonstrate that 56% of the interviewed ones that they had answered to the questionnaire they were of the masculine sex and 44% of the feminine sex.
In accordance with Botelho and Christmas (2009), Calculating the coefficient of incidence as sex are possible to observe that the risk of adoecer for Leishmaniose is bigger in the masculine sex. GRAPH 02 – Age of the people interviewed in Oath.